ArticleCell and tissue research2026
Aldosterone induced by chronic stress promotes pancreatic steatosis in young male rats.
Article in Cell and tissue research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The impact of mineralocorticoid receptor antagonists on fat mass and fat metabolism.Journal of endocrinological investigation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aldosterone, a stress-related hormone, may contribute to pancreatic dysfunction. Its role in pancreatic physiology, inflammation, and fibrosis remains poorly understood. This study aimed to evaluate the effects of aldosterone on pancreatic histomorphology and islet cellularity under chronic stress conditions, and to determine whether eplerenone, a selective aldosterone receptor antagonist, can counteract them. Twenty-four young male Wistar rats were randomly divided into four groups (n = 6): control, chronic unpredictable mild stress (CUMS), control + vehicle (control + Veh), and CUMS + eplerenone (EP). Eplerenone was administered on postnatal day 51 via gastric tube 2 h before daily stress exposure for 4 weeks. Histological, immunohistochemical, and biochemical analyses were performed, including quantification of aldosterone, visceral adipose tissue, and pancreatic triacylglycerol. In CUMS group, the aldosterone level increased. In the exocrine pancreas, the aldosterone increased intralobular fat and triacylglycerol accumulation. Tumor necrosis factor alpha (TNFα)-positive necrotic acinar cells with pyknotic nuclei and perivascular fibrosis were evident. The endocrine pancreas exhibited increased inflammation and an altered distribution of islet sizes. Eplerenone reduced fat accumulation, inflammation, and exocrine structural damage but did not prevent TNF-α expression in islets. In conclusion, aldosterone induced by chronic stress contributes to pancreatic steatosis, and islet toxicity in young male rats, supporting aldosterone's pathogenic role.
Indexed as
Identifiers
41543613What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.